The Marked Chart Wire · Business
Sanofi
Sanofi boosts earnings forecast driven by Dupixent demand
The pharmaceutical company raised its annual profit target, citing solid performance from its top-selling drug Dupixent.
The stocks in this story
Prices from Based on Fri, Oct 30 close · Opens Mon 9:30 AM ET. Each tile opens the stock's chart and news.
New to this? Read: Reading a stock chart
More Business news
Sanofi
Sanofi third-quarter earnings rise 22 percent
Sanofi reported third-quarter business EPS of 3.55 euros, a 22 percent increase. Sales reached 14.44 billion euros, up 16.2 percent, or 14.3 percent at constant exchange rates.
Sanofi
Sanofi beats expectations and lifts full year 2026 outlook
The pharmaceutical company reported quarterly results that exceeded analyst forecasts for both revenue and profit. Sanofi subsequently raised its guidance for the full fiscal year 2026.
SpaceX Tesla Merger
SpaceX and Tesla reportedly exploring a potential merger
SpaceX and Tesla are said to be considering a merger, a move some analysts view as strategically unsound.
ExxonMobil
ExxonMobil plans $20 billion in 2027 share buybacks
ExxonMobil intends to repurchase $20 billion of its stock in 2027. The company's CEO addressed market concerns regarding oil prices during a recent discussion.
SpaceX Tesla Merger
SpaceX and Tesla reportedly weigh formal merger talks
The two companies are said to be formally evaluating a potential combination, with success hinging on a specific condition.
HotQualcomm
Qualcomm shares drop 11 percent after Intel PC warning
Qualcomm stock fell 11 percent to $164.79 following a warning from Intel regarding the personal computer market. The decline raises questions about whether smartphone sales have stabilized.
Fast headlines, summarized. Not verified and not advice. Check the full story before you act.